Active pharmaceutical ingredients manufacturer Supriya Lifescience made a strong debut on the bourses on Tuesday with the stock listing at ...

“We like Supriya for its niche product portfolio, backward integrated business model and robust financials. It is well placed to tap the op...

The Rs 700 crore-IPO by the API manufacturer was sold from December 16 to 20 and was subscribed nearly 72 times, with the IPO getting fully...

Dealers active in the unofficial market for unlisted shares said HP Adhesives was trading at a premium of 34 per cent or Rs 90-97 per share...

The IPO was fully subscribed within a few hours of opening for subscription on the back of a strong response from retail investors.

The ₹700 crore initial public offering of pharmaceutical ingredients supplier Supriya Lifescience was subscribed 71.47 times on Monday, the...

According to data from BSE, the portion reserved for retail bidders was subscribed 41.14 times, whereas HNI portion was subscribed about 14...

The company has received majorly positive reviews from the analysts, who are bullish on the API manufacturer thanks to competitive pricing,...

Supriya Lifescience is a manufacturer and supplier of active pharmaceutical ingredients (APIs) that go into medicines, with a strong focus ...

A day before the IPO, Supriya Lifesciences raised Rs 315 crore from 18 anchor investors, allocating them 1,14,96,351 equity shares for Rs 2...

Active pharmaceutical ingredient (API) manufacturer Supriya Lifescience has a niche basket of 38 APIs across therapeutic segments and it ea...

The company has allotted 1.15 crore equity shares to anchor investors at Rs 274 apiece, which is the upper end of the price band, aggregati...

Investors can bid for a minimum of 54 equity shares and in multiple of 54 thereof. The IPO can be subscribed till December 20, Monday. The ...

According to data available with the stock exchanges, so far this fiscal, 12 firms have raised Rs 27,000 crore from IPOs, and Rs 70,000-cro...

The six firms, which had filed their respective preliminary IPO papers with the markets regulator between May and June, obtained their obse...

At least 12 drug makers and healthcare companies are planning IPOs in 2021 as the pandemic increases investor demand for the promising play...

The IPO consists of a fresh issue of shares worth Rs 200 crore and an offer of sale (OFS) of shares worth up to Rs 1,000 crore held by its ...